 | • レポートコード：QYR9N7870 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、産後うつ病治療薬のグローバル市場について調査・分析したレポートで、種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミンオキシダーゼ阻害剤）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・産後うつ病治療薬の世界市場規模 ・主要企業別市場シェア ・産後うつ病治療薬の世界市場規模：種類別（選択的セロトニン再取り込み阻害薬、セロトニンノルエピネフリン再取り込み阻害薬、三環系抗うつ薬、モノアミンオキシダーゼ阻害剤） ・産後うつ病治療薬の世界市場規模：用途別（病院薬局、オンライン薬局、小売薬局） ・産後うつ病治療薬のアメリカ市場規模（種類別、用途別） ・産後うつ病治療薬のヨーロッパ市場規模（種類別、用途別） ・産後うつ病治療薬の中国市場規模（種類別、用途別） ・産後うつ病治療薬の日本市場規模（種類別、用途別） ・産後うつ病治療薬の東南アジア市場規模（種類別、用途別） ・産後うつ病治療薬のインド市場規模（種類別、用途別） ・産後うつ病治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・産後うつ病治療薬の世界市場予測（2019年-2025年） ・産後うつ病治療薬の地域別市場予測（2019年-2025年） ... |
Postpartum depression is a prevalent disorder affecting many women of reproductive age.Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depression.
In 2018, the global Postpartum Depression Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Postpartum Depression Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Postpartum Depression Therapeutics development in United States, Europe and China.
The key players covered in this study
Pfizer
Allegan
Eli Lilly
H. Lundbeck
GlaxoSmithKline
Solvay
AstraZeneca
Novartis
Sage Therapeutics
Market segment by Type, the product can be split into
Selective Serotonin Reuptake Inhibitors
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Postpartum Depression Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Postpartum Depression Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Postpartum Depression Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Postpartum Depression Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Selective Serotonin Reuptake Inhibitors
1.4.3 Serotonin Norepinephrine Reuptake Inhibitors
1.4.4 Tricyclic Antidepressants
1.4.5 Monoamine Oxidase Inhibitors
1.5 Market by Application
1.5.1 Global Postpartum Depression Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Postpartum Depression Therapeutics Market Size
2.2 Postpartum Depression Therapeutics Growth Trends by Regions
2.2.1 Postpartum Depression Therapeutics Market Size by Regions (2014-2025)
2.2.2 Postpartum Depression Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Postpartum Depression Therapeutics Market Size by Manufacturers
3.1.1 Global Postpartum Depression Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Postpartum Depression Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Postpartum Depression Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Postpartum Depression Therapeutics Key Players Head office and Area Served
3.3 Key Players Postpartum Depression Therapeutics Product/Solution/Service
3.4 Date of Enter into Postpartum Depression Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Postpartum Depression Therapeutics Market Size by Type (2014-2019)
4.2 Global Postpartum Depression Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Postpartum Depression Therapeutics Market Size (2014-2019)
5.2 Postpartum Depression Therapeutics Key Players in United States
5.3 United States Postpartum Depression Therapeutics Market Size by Type
5.4 United States Postpartum Depression Therapeutics Market Size by Application
6 Europe
6.1 Europe Postpartum Depression Therapeutics Market Size (2014-2019)
6.2 Postpartum Depression Therapeutics Key Players in Europe
6.3 Europe Postpartum Depression Therapeutics Market Size by Type
6.4 Europe Postpartum Depression Therapeutics Market Size by Application
7 China
7.1 China Postpartum Depression Therapeutics Market Size (2014-2019)
7.2 Postpartum Depression Therapeutics Key Players in China
7.3 China Postpartum Depression Therapeutics Market Size by Type
7.4 China Postpartum Depression Therapeutics Market Size by Application
8 Japan
8.1 Japan Postpartum Depression Therapeutics Market Size (2014-2019)
8.2 Postpartum Depression Therapeutics Key Players in Japan
8.3 Japan Postpartum Depression Therapeutics Market Size by Type
8.4 Japan Postpartum Depression Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Postpartum Depression Therapeutics Market Size (2014-2019)
9.2 Postpartum Depression Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Postpartum Depression Therapeutics Market Size by Type
9.4 Southeast Asia Postpartum Depression Therapeutics Market Size by Application
10 India
10.1 India Postpartum Depression Therapeutics Market Size (2014-2019)
10.2 Postpartum Depression Therapeutics Key Players in India
10.3 India Postpartum Depression Therapeutics Market Size by Type
10.4 India Postpartum Depression Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Postpartum Depression Therapeutics Market Size (2014-2019)
11.2 Postpartum Depression Therapeutics Key Players in Central & South America
11.3 Central & South America Postpartum Depression Therapeutics Market Size by Type
11.4 Central & South America Postpartum Depression Therapeutics Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Postpartum Depression Therapeutics Introduction
12.1.4 Pfizer Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Allegan
12.2.1 Allegan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Postpartum Depression Therapeutics Introduction
12.2.4 Allegan Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.2.5 Allegan Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Postpartum Depression Therapeutics Introduction
12.3.4 Eli Lilly Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 H. Lundbeck
12.4.1 H. Lundbeck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Postpartum Depression Therapeutics Introduction
12.4.4 H. Lundbeck Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.4.5 H. Lundbeck Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Postpartum Depression Therapeutics Introduction
12.5.4 GlaxoSmithKline Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Solvay
12.6.1 Solvay Company Details
12.6.2 Company Description and Business Overview
12.6.3 Postpartum Depression Therapeutics Introduction
12.6.4 Solvay Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.6.5 Solvay Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Postpartum Depression Therapeutics Introduction
12.7.4 AstraZeneca Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Postpartum Depression Therapeutics Introduction
12.8.4 Novartis Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Sage Therapeutics
12.9.1 Sage Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Postpartum Depression Therapeutics Introduction
12.9.4 Sage Therapeutics Revenue in Postpartum Depression Therapeutics Business (2014-2019)
12.9.5 Sage Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Postpartum Depression Therapeutics Key Market Segments
Table Key Players Postpartum Depression Therapeutics Covered
Table Global Postpartum Depression Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Postpartum Depression Therapeutics Market Size Market Share by Type 2014-2025
Figure Selective Serotonin Reuptake Inhibitors Figures
Table Key Players of Selective Serotonin Reuptake Inhibitors
Figure Serotonin Norepinephrine Reuptake Inhibitors Figures
Table Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Figure Tricyclic Antidepressants Figures
Table Key Players of Tricyclic Antidepressants
Figure Monoamine Oxidase Inhibitors Figures
Table Key Players of Monoamine Oxidase Inhibitors
Table Global Postpartum Depression Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Postpartum Depression Therapeutics Report Years Considered
Table Global Postpartum Depression Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Postpartum Depression Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Postpartum Depression Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Postpartum Depression Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Postpartum Depression Therapeutics Market Share by Regions 2014-2019
Figure Global Postpartum Depression Therapeutics Market Share by Regions 2014-2019
Figure Global Postpartum Depression Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Postpartum Depression Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Postpartum Depression Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Postpartum Depression Therapeutics Market Share by Manufacturers in 2018
Table Global Postpartum Depression Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Postpartum Depression Therapeutics Product/Solution/Service
Table Date of Enter into Postpartum Depression Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Postpartum Depression Therapeutics Market Size Share by Type (2014-2019)
Figure Global Postpartum Depression Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Postpartum Depression Therapeutics Market Size Share by Application (2014-2019)
Figure Global Postpartum Depression Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Postpartum Depression Therapeutics Revenue Market Share by Application in 2018
Figure United States Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table United States Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table United States Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure Europe Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table Europe Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table Europe Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure China Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table China Postpartum Depression Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table China Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure Japan Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table Japan Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table Japan Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table Southeast Asia Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure India Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table India Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table India Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Postpartum Depression Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Postpartum Depression Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Postpartum Depression Therapeutics Market Share (2018-2019)
Table Central & South America Postpartum Depression Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Postpartum Depression Therapeutics Market Share by Type (2014-2019)
Table Central & South America Postpartum Depression Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Postpartum Depression Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Postpartum Depression Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Allegan Company Details
Table Allegan Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure Allegan Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Allegan Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table H. Lundbeck Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Solvay Company Details
Table Solvay Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure Solvay Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Solvay Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Sage Therapeutics Company Details
Table Sage Therapeutics Revenue in Postpartum Depression Therapeutics Business (2014-2019)(Million US$)
Figure Sage Therapeutics Revenue Growth Rate in Postpartum Depression Therapeutics Business (2014-2019)
Table Sage Therapeutics Recent Development
Table Global Postpartum Depression Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Postpartum Depression Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Postpartum Depression Therapeutics Market Size Share by Regions in 2025
Figure United States Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Postpartum Depression Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Postpartum Depression Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Postpartum Depression Therapeutics Market Size by Product (2019-2025)
Figure Global Postpartum Depression Therapeutics Market Size by Product in 2025
Table Global Postpartum Depression Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Postpartum Depression Therapeutics Market Size by Application (2019-2025)
Figure Global Postpartum Depression Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の産後うつ病治療市場2019 The global Postpartum Depression Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Postpartum Depression Treatment market status and forecast, categorizes the global Postpartum Depre…- 世界のうつ病性障害市場：市場規模・現状・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
- 世界のCox-2阻害剤市場：市場規模・現状・予測 Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.In 2018, the global Cox-2 Inhibitors market size was …
- 世界のうつ病治療市場：市場規模・現状・予測 Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest.One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the t…
- 世界のシグナル伝達阻害剤市場：市場規模・現状・予測 Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibito…